Artificial intelligence in ischemic retinopathy: from diagnostic and predictive performance to clinical translation

Artificial intelligence (AI) is increasingly being applied to retinal imaging for the detection, characterization, monitoring, and prediction of ischemic retinal disease. This narrative review examines the clinical applications and translational development of AI across retinopathy of prematurity (ROP), diabetic retinopathy (DR), and retinal vein occlusion (RVO). A structured literature search identified 18 primary studies spanning diagnosis and disease characterization, predictive and longitudinal applications, and clinical implementation. AI demonstrated strong performance across several imaging tasks, including plus-disease detection, DR detection and grading, RVO classification, angiographic interpretation, vascular quantification, and image-quality assessment. Predictive evidence of future clinical outcomes was more limited, with studies addressing ROP risk and short-term treatment response in RVO, while separate studies evaluated longitudinal vascular severity assessment in ROP. Translational maturity differed across diseases: DR had the strongest prospective and autonomous screening evidence, ROP had progressed toward quantitative assessment, prediction, and telemedicine support, and RVO remained predominantly at the retrospective development stage. Across all three diseases, high model performance did not necessarily indicate clinical readiness. Generalizability, image quality, interpretability, prospective validation, workflow integration, and evidence of downstream benefit remain important barriers to translation. The clinical value of retinal AI will ultimately depend not on achieving the highest performance metric, but on performing meaningful tasks reliably across settings and improving how patients are evaluated, referred, monitored, and treated.

Authors

Institutions

Publication Details

Journal
Frontiers in Artificial Intelligence
Published
2026-11-17
DOI
https://doi.org/10.3389/frai.2026.1994986
Primary Topic
Retinal Imaging and Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Artificial intelligence in ischemic retinopathy: from diagnostic and predictive performance to clinical translation

Menaka Chanu Thounaojam, Pamela Moore Martin, Ravirajsinh Navalsinh Jadeja, Briah Bailey et al.
Frontiers in Artificial Intelligence
Retinal Imaging and Analysis
article

Artificial intelligence in ischemic retinopathy: from diagnostic and predictive performance to clinical translation

Menaka Chanu Thounaojam, Pamela Moore Martin, Ravirajsinh Navalsinh Jadeja, Briah Bailey, Sewedo B. Ajisegiri, Ronny Amamoo, Fapianey J. Alexandre, Aleah J. Brokemond
article en

Abstract

Artificial intelligence (AI) is increasingly being applied to retinal imaging for the detection, characterization, monitoring, and prediction of ischemic retinal disease. This narrative review examines the clinical applications and translational development of AI across retinopathy of prematurity (ROP), diabetic retinopathy (DR), and retinal vein occlusion (RVO). A structured literature search identified 18 primary studies spanning diagnosis and disease characterization, predictive and longitudinal applications, and clinical implementation. AI demonstrated strong performance across several imaging tasks, including plus-disease detection, DR detection and grading, RVO classification, angiographic interpretation, vascular quantification, and image-quality assessment. Predictive evidence of future clinical outcomes was more limited, with studies addressing ROP risk and short-term treatment response in RVO, while separate studies evaluated longitudinal vascular severity assessment in ROP. Translational maturity differed across diseases: DR had the strongest prospective and autonomous screening evidence, ROP had progressed toward quantitative assessment, prediction, and telemedicine support, and RVO remained predominantly at the retrospective development stage. Across all three diseases, high model performance did not necessarily indicate clinical readiness. Generalizability, image quality, interpretability, prospective validation, workflow integration, and evidence of downstream benefit remain important barriers to translation. The clinical value of retinal AI will ultimately depend not on achieving the highest performance metric, but on performing meaningful tasks reliably across settings and improving how patients are evaluated, referred, monitored, and treated.

Frontiers in Artificial IntelligenceVol. 9
Meharry Medical College (US)
Good health and well-being
Retinal Imaging and Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon